Test Code CHLAP Chlamydia IgM and IgG Panel, Immunofluorescence, Serum
Ordering Guidance
For suspected Chlamydia trachomatis infection, order either CTRNA / Chlamydia trachomatis, Nucleic Acid Amplification, Varies or CGRNA / Chlamydia trachomatis and Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies.
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.6 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Useful For
Aiding in the clinical diagnosis of Chlamydia pneumoniae or Chlamydia psittaci infection
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CHLG | Chlamydia IgG, IFA, S | Yes | Yes |
CHLM | Chlamydia IgM, IFA, S | Yes | Yes |
Method Name
Micro-Immunofluorescent Antibody (MIF) Assay
Reporting Name
Chlamydia IgM/IgG Panel, IFA, SSpecimen Type
SerumSpecimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 30 days | |
Frozen | 30 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Heat-inactivated specimen | Reject |
Reference Values
Chlamydia pneumoniae
IgM: <1:10
IgG: <1:64
Chlamydia psittaci
IgM: <1:10
IgG: <1:64
Interpretation
IgM
Chlamydia pneumoniae and Chlamydia psittaci
≥1:10
IgM endpoint titers of 1:10 or more are considered presumptive evidence of infection.
<1:10
IgM endpoint titers below 1:10 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels.
IgG:
C pneumoniae
≥1:512
IgG endpoint titers of 1:512 or more are considered presumptive evidence of current infection.
≥1:64 and <1:512
A single specimen endpoint titer of 1:64 to 1:512 should be considered evidence of infection at an undetermined time. A second specimen collected 10 to 21 days after the original collection should be tested in parallel with the first. If the second specimen exhibits a titer 1:512 or more or a 4-fold increase over that of the initial specimen, current (acute) infection is indicated. Unchanging titers from 1:64 to 1:512 suggest past infection.
<1:64
IgG endpoint titers below 1:64 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels.
C pneumoniae antibody is detectable in 25% to 45% of adults tested.
C psittaci
≥1:64
IgG endpoint titers of 1:64 or more are considered presumptive evidence of current infection.
<1:64
IgG endpoint titers below 1:64 suggest that the patient does not have a current infection. These antibody levels may be found in patients with either no history of chlamydial infection or those with past infection whose antibody levels have dropped below detectable levels.
Day(s) Performed
Monday, Thursday
Report Available
Same day/1 to 4 daysPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
86632 x 2
86631 x 2
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CHLAP | Chlamydia IgM/IgG Panel, IFA, S | 77166-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
619392 | C. pneumoniae IgG | In Process |
619390 | C. pneumoniae IgM | In Process |
619391 | C. psittaci IgM | In Process |
619393 | C. psittaci IgG | In Process |
Forms
If not ordering electronically, complete, print, and send an Infectious Disease Serology Test Request (T916) with the specimen.